These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14734114)

  • 1. Recent developments in MHC-class-I-mediated antigen presentation.
    Lehner PJ; Cresswell P
    Curr Opin Immunol; 2004 Feb; 16(1):82-9. PubMed ID: 14734114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the TAP-like transporter in antigen presentation and phagosome maturation.
    Lawand M; Evnouchidou I; Baranek T; Montealegre S; Tao S; Drexler I; Saveanu L; Si-Tahar M; van Endert P
    Mol Immunol; 2019 Sep; 113():75-86. PubMed ID: 29941219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.
    Ackerman AL; Kyritsis C; Tampé R; Cresswell P
    Nat Immunol; 2005 Jan; 6(1):107-13. PubMed ID: 15592474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GTPase Rab39a promotes phagosome maturation into MHC-I antigen-presenting compartments.
    Cruz FM; Colbert JD; Rock KL
    EMBO J; 2020 Jan; 39(2):e102020. PubMed ID: 31821587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways of MHC I cross-presentation of exogenous antigens.
    Cruz FM; Chan A; Rock KL
    Semin Immunol; 2023 Mar; 66():101729. PubMed ID: 36804685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasomal degradation within endocytic organelles mediates antigen cross-presentation.
    Sengupta D; Graham M; Liu X; Cresswell P
    EMBO J; 2019 Aug; 38(16):e99266. PubMed ID: 31271236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are ERAD components involved in cross-presentation?
    Grotzke JE; Cresswell P
    Mol Immunol; 2015 Dec; 68(2 Pt A):112-5. PubMed ID: 26005101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology. Nothing 'gainst time's scythe can make defense..
    Ploegh HL
    Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathways for antigen cross presentation.
    Guermonprez P; Amigorena S
    Springer Semin Immunopathol; 2005 Jan; 26(3):257-71. PubMed ID: 15592842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens.
    Ackerman AL; Kyritsis C; Tampé R; Cresswell P
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12889-94. PubMed ID: 14561893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-presentation of exogenous antigens on MHC I molecules.
    Colbert JD; Cruz FM; Rock KL
    Curr Opin Immunol; 2020 Jun; 64():1-8. PubMed ID: 31927332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.
    Segura E; Villadangos JA
    Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comings and goings of MHC class I molecules herald a new dawn in cross-presentation.
    Blander JM
    Immunol Rev; 2016 Jul; 272(1):65-79. PubMed ID: 27319343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagosomes are competent organelles for antigen cross-presentation.
    Houde M; Bertholet S; Gagnon E; Brunet S; Goyette G; Laplante A; Princiotta MF; Thibault P; Sacks D; Desjardins M
    Nature; 2003 Sep; 425(6956):402-6. PubMed ID: 14508490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exiting the outside world for cross-presentation.
    Rock KL
    Immunity; 2006 Oct; 25(4):523-5. PubMed ID: 17046678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation.
    Oh YK; Harding CV; Swanson JA
    Vaccine; 1997 Apr; 15(5):511-8. PubMed ID: 9160518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
    Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
    Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.